dc.contributor.author |
JOSEPH, LINCY |
|
dc.contributor.author |
GEORGE, MATHEW |
|
dc.contributor.author |
RANGA RAO B, VENKATA |
|
dc.date.accessioned |
2022-11-29T05:17:25Z |
|
dc.date.available |
2022-11-29T05:17:25Z |
|
dc.date.issued |
2008-07-13 |
|
dc.identifier.citation |
Joseph, L., Mathew, G., & Rao, V. R. (2008). Simultaneous estimation of atorvastatin and ramipril by RP-HPLC and spectroscopy. Pakistan Journal of Pharmaceutical Sciences, 21(3), 282-285. |
en_US |
dc.identifier.issn |
1011-601X |
|
dc.identifier.uri |
http://142.54.178.187:9060/xmlui/handle/123456789/14181 |
|
dc.description.abstract |
A number of analytical methods were reported for the estimation of atorvastatin and ramipril from their
individual dosage forms or in combination with other drugs (Valiyare, 2004; Vachareau and Neirinck, 2000).
Here successful reverse phase-high performance liquid chromatographic method and spectroscopic methods
developed then validated for the analysis of combined dosage form of atorvastatin and ramipril . Individual λmax for atorvastatin is 247 n.m and that of ramipril is 208 n.m. They intercept at 215 n.m which is fixed as
wavelength for reverse phase-high performance liquid chromatographic method. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Karachi: Faculty of Pharmacy & Pharmaceutical Sciences, Karachi |
en_US |
dc.subject |
Atorvastatin |
en_US |
dc.subject |
Ramipril |
en_US |
dc.subject |
RP-HPLC |
en_US |
dc.subject |
intersil-ODS |
en_US |
dc.subject |
Acetonitrile |
en_US |
dc.subject |
Vierodt’s equation |
en_US |
dc.title |
SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND RAMIPRIL BY RP-HPLC AND SPECTROSCOPY |
en_US |
dc.type |
Article |
en_US |